 "Bharat Biotech, Covaxin")
The World Health Organization said on Monday it expects Bharat Biotech to provide more information on its COVID-19 vaccine in a further setback to the Indian company's hopes of getting an emergency-use listing for the shot.
Without WHO's nod the two-dose Covaxin is unlikely to be accepted as a valid COVID-19 vaccine around the world. Bharat Biotech has been pursuing a WHO emergency-use listing for several months, having submitted data on a rolling basis since July.
"We are aware that many people are waiting for WHO's recommendation for (Bharat Biotech's) Covaxin to be included in the #COVID19 Emergency Use Listing,
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
